.jpg)
Nasdaq (Nasdaq:NDAQ) announces today the updated results of the semi-annual review of the First North 25 Index (Nasdaq Stockholm: FN25) which will become effective with the market open on Monday, July 2, 2018.
As per the announcement on June 18, 2018, Magnolia Bostad AB has moved from Nasdaq First North to Main Market Sweden on June 20, 2018. As a result, the new portfolio effective July 2, 2018 has been adjusted for this change.
Cibus Nordic Real Estate AB (CIBUS), HRC World Plc (HRC), Infant Bacterial Therapeutics (IBT B), Kvika banki hf. (KVIKA), Sdiptech AB B (SDIP B), Sedana Medical AB (SEDANA), Stillfront Group AB (SF) and Vostok Emerging Finance Ltd (VEMF SDB) will be added to the portfolio and Cognosec AB (COGS). IRLAB Therapeutics AB ser. A (IRLAB A) and Prime Living AB (PRIME) will exit the portfolio.
The FN25 consists of the largest and most traded shares listed on Nasdaq First North. Companies included in the FN25 are selected through a two-step process as follows:
- The 30 largest companies measured by market capitalization are selected.
- The 25 most traded shares within this pool, measured by aggregated trading turnover over a six month period, are selected for the index.
FN25 is reviewed semi-annually in January and July.
The First North 25 Index constituents effective July 2, 2018 are:
| Aspire Global plc | Next Games Oyj |
| BIMobject AB | Nordic Leisure AB |
| Cibus Nordic Real Estate AB | Paradox Interactive AB |
| Cinnober Financial Technology | PowerCell Sweden AB |
| Climeon AB ser. B | SaltX Technology Holding AB ser. B |
| Detection Technology Oyj | Samhällsbyggnadsbolaget i Norden AB ser. B |
| Fastighets AB Trianon ser. B | Sedana Medical AB |
| Global Gaming 555 AB | Sdiptech AB B |
| GomSpace Group AB | Stillfront Group AB |
| HRC World Plc | THQ Nordic AB ser. B |
| Infant Bacterial Therapeutics AB ser B. | Verkkokauppa.com Oyj |
| Kambi Group plc | Vostok Emerging Finance Ltd |
| Kvika banki hf. |
